8. May 2026
Professor Christiane Pauli-Magnus elected to Swiss TPH Board of Governors
Professor Christiane Pauli-Magnus, Co-Director of the Department of Clinical Research at the University of Basel and University Hospital Basel, has been elected to the Board of Governors of the Swiss Tropical and Public Health Institute (Swiss TPH) with effect from 1 April 2026. The DKF congratulates her on this election.
Professor Christiane Pauli-Magnus has been Co-Director of the Department of Clinical Research since 2014. She is also a Board member of the Swiss Clinical Trial Organisation, which she chaired from 2017 to 2025, and a member of the Swiss Science Council.
The government of the Canton of Basel-Landschaft elected Pauli-Magnus to the Board of Governors of Swiss TPH with effect from 1 April 2026. She succeeds Sabina De Geest, who served on the Board of Governors for 17 years.
Expertise in clinical research and medicine
“I would like to welcome Christiane Pauli-Magnus to our Board of Governors,” says Jürg Utzinger, Director of Swiss TPH. “Her many years of experience and broad expertise in clinical research and medicine, as well as in the Swiss scientific landscape, will complement the Board.”
Pauli-Magnus studied medicine in Heidelberg and Würzburg and obtained her doctorate in 1996 after spending semesters abroad in France and Chile. She is a specialist in general internal medicine and clinical pharmacology and titular professor of clinical pharmacology and toxicology at the University of Basel.
"I am very honoured to have been elected to the Board of Governors of Swiss TPH and look forward to contributing to the further development of an institution that plays an important role for Basel as a life sciences hub and far beyond."
Professor Christiane Pauli-Magnus, Co-Director DKF
Swiss TPH is an associated institute of the University of Basel and combines research, education and services in global health. Its Board of Governors is the institute’s highest decision-making and supervisory body and is responsible for strategic direction, governance, budget and risk management.